Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer
Clinical trial NCT06766019 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06766019
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2027-09-30
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.